Mez_BCNACommunity Manager4 years agoTrodelvy approved for PBSBCNA welcomes yesterday's announcement to list Trodelvy® (sacituzumab govitecan) to the Pharmaceutical Benefits Scheme (PBS). Check out the article for full details of this news and eligibility https...Show More
Recent DiscussionsOncotype DX and RibociclibRadiation Therapy OmissionBest Bra's post surgeryWIDER clinical trialAnastrozole and vertigo